
Breztri Aerosphere: Uses, Dosage, Side Effects, Warnings - Drugs.com
Dec 2, 2025 · Breztri (budesonide/glycopyrrolate/formoterol fumarate) is a combination inhaler used for the long-term treatment of chronic obstructive pulmonary disease (COPD) in adults. …
Using Inhalers for COPD - BREZTRI AEROSPHERE
Learn how to use your BREZTRI inhaler with these simple, video-based instructions.
Breztri Aerosphere: Side Effects, Cost, Dosage, and More
Nov 21, 2025 · Learn about cost, side effects, and more for Breztri Aerosphere, which is a prescription inhaler that treats COPD in adults.
Breztri Aerosphere (budesonide/glycopyrrolate/formoterol ... - WebMD
Jun 28, 2024 · Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) is commonly used for chronic obstructive pulmonary disease (COPD), including emphysema and chronic …
Breztri Aerosphere: Generic, side effects, dosage, and more
May 27, 2025 · Breztri Aerosphere is a brand-name metered-dose inhaler prescribed to treat long-term chronic obstructive pulmonary disease (COPD) in adults. Breztri Aerosphere contains the …
Breztri Aerosphere - RxList
Jan 31, 2023 · BREZTRI AEROSPHERE combines 3 medicines, an inhaled corticosteroid (ICS) medicine (budesonide), an anticholinergic medicine (glycopyrrolate), and a long-acting beta 2 …
DailyMed - BREZTRI- budesonide, glycopyrrolate, and …
Jan 26, 2022 · Inhalation aerosol: a pressurized metered dose inhaler that delivers a combination of 160 mcg budesonide, 9 mcg glycopyrrolate, and 4.8 mcg formoterol fumarate per inhalation.
Breztri: Package Insert / Prescribing Information / MOA
Dec 2, 2024 · BREZTRI AEROSPHERE is a combination of budesonide, an inhaled corticosteroid (ICS); glycopyrrolate, an anticholinergic; and formoterol fumarate, a long-acting beta 2 …
Breztri: Uses, Side Effects, Alternatives & More - GoodRx
Sep 11, 2024 · Breztri Aerosphere is a combination inhaler that contains budesonide (an inhaled corticosteroid), glycopyrrolate (a long-acting muscarinic antagonist), and formoterol (a long …
When beginning treatment with BREZTRI AEROSPHERE, patients who have been taking rapid onset, short duration, inhaled beta2-agonists on a regular basis should be instructed to …